RxSight price target lowered to $6.50 from $7.50 at Jefferies
Target downgrade suggests reduced upside.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Target downgrade suggests reduced upside.
What happened, with direct paths to the underlying reporting
Jefferies lowers target to $6.50; current price is $5.62.
Target: $6.5
Posted price: $5.62
Analyst firm: Jefferies
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.